GlassScriptPhysician profile
Debra Hudock
NPI 1134367246
$3,140.31
in general payments reported to CMS, 2019-2025
10 companies · $795 in 2025
The $795 reported for 2025 was more than what 85% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $819 · 2022: $910 · 2023: $319 · 2024: $298 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Consulting Fee: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.37 |
| Consulting Fee | $506.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $2,659.51 | 2021-2025 | Tyvaso, Orenitram, Remodulin |
| Insmed, INC. | $182.14 | 2023-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.84 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $36.51 | 2021 | |
| Abbott Laboratories | $35.42 | 2023-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $27.11 | 2021-2023 | Farxiga |
| Pfizer INC. | $23.31 | 2022 | |
| Scpharmaceuticals INC. | $15.86 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Hudock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.